Stroke Management Global Market Rising Trends, Industry Size, Share Report, Growing Demand and Business Opportunities And Forecast 2024-2033

Spread the love

Overview and Scope
Stroke management refers to a treatment that occurs when a blood vessel in the brain bursts or when something stops the flow of blood to a specific area of the brain. The brain either ages or suffers harm in both scenarios.

Sizing and Forecast
The stroke management market size has grown strongly in recent years. It will grow from $36.94 billion in 2023 to $39.98 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to thrombolytic therapies, stroke prevention initiatives, rehabilitation techniques, telemedicine in stroke care, collaborative stroke networks.

The stroke management market size is expected to see strong growth in the next few years. It will grow to $52.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to emergence of neuroprotective therapies, artificial intelligence in stroke diagnosis, personalized medicine approaches, expanding access to acute care, global stroke care standardization. Major trends in the forecast period include advancements in medical imaging technology, telemedicine and remote monitoring, focus on preventive care and risk factor management, neuroprotective therapies and drug innovations, collaboration and multidisciplinary approaches.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/stroke-management-global-market-report

Segmentation & Regional Insights
The stroke management market covered in this report is segmented –
1) By Product Type: Diagnostics, Drug Therapy Products, Interventional Stroke Management Systems
2) By Application: Ischemic Stroke, Hemorrhagic Stroke
3) By End-User: Hospitals, Clinics, Ambulatory Surgery Centers, Diagnostic Centers, Retail Pharmacies, Online Pharmacies, Other End Users

North America was the largest region in the stroke management market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global stroke management market report during the forecast period. The regions covered in the stroke management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9988&type=smp

Major Driver Impacting Market Growth
The increasing incidence of chronic diseases is expected to propel the growth of the stroke management market going forward. Chronic diseases refer to a problem that persists for a year or longer and impedes everyday activities, necessitates continuing medical care, or both. Stroke management assists patients suffering from various chronic diseases, such as cancer and cardiovascular diseases, by providing a timely focus on preventive, care, and support requirements through patient education and empowerment as well as the creation of care delivery models that integrate primary and secondary care. For instance, in January 2023, according to the National Library of Medicine a US-based biomedical library highlights, there will be 142.66 million people aged 50 and older in 2050 who have at least one chronic disease, up from 71.522 million in 2020, a 99.5% rise. Therefore, the increasing incidence of chronic diseases is driving the growth of the stroke management market going forward.

Key Industry Players
Major companies operating in the stroke management market report are GE HealthCare Technologies Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Bristol Myers Squibb Co., Cardinal Health Inc., Glaxosmithkline Plc, Siemens AG, Merck And Co. Inc., Asahi Intech Co. Ltd., Johnson & Johnson, Penumbra Inc., Teleflex Inc., Stryker Corporation, Biogen Inc., Bayer AG, Philips Healthcare, AstraZeneca Plc., F. Hoffmann-la Roche, Novartis AG, Takeda Pharmaceutical Company Ltd., Sanofi SA, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Pfizer Inc., Integer Holdings Corporation

The stroke management market report table of contents includes:
1. Executive Summary